Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

IMPORTANCE Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14,276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% CI, 2.83-10.61; P = 4.4 × 10(-7)) in hepatocyte nuclear factor 1-α (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% CI, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.

[1]  S. Fajans,et al.  Maturity Onset Diabetes of the Young (MODY) , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[2]  S. Villalpando,et al.  Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population. A probabilistic survey [Prevalencia y distribución de la diabetes mellitus tipo 2 en población adulta mexicana. Una encuesta probabilística.] , 2010 .

[3]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[4]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[5]  J. Halter,et al.  Maturity Onset Diabetes of the Young (MODY) , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[6]  M. Daly,et al.  Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.

[7]  Peter Kraft,et al.  Analysis of case-control association studies with known risk variants , 2012, Bioinform..

[8]  J. Halter,et al.  Maturity-onset diabetes of the young. , 1994, Life sciences.

[9]  M. McCarthy,et al.  Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK , 2011, Diabetologia.

[10]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[11]  H. Ledermann,et al.  Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? , 1995, Diabetologia.

[12]  A. Molven,et al.  Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study) , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[13]  M. Yaniv,et al.  HNF1, a homeoprotein member of the hepatic transcription regulatory network , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  Jacob A. Tennessen,et al.  Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes , 2012, Science.

[15]  Y. Horikawa,et al.  High frequency of mutations in the HNF-1α gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance , 2002, Diabetologia.

[16]  C. Bellanné-Chantelot,et al.  The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 , 2008, Diabetes.

[17]  Kari Stefansson,et al.  Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes , 2014, Nature Genetics.

[18]  Stefan Johansson,et al.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes , 2013, Nature Genetics.

[19]  B. Shields,et al.  A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[20]  S. Haffner,et al.  The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. , 2005, Diabetes care.

[21]  Tanya M. Teslovich,et al.  Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility , 2014, Nature Genetics.

[22]  B. Zinman,et al.  The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. , 1999, The Journal of clinical endocrinology and metabolism.

[23]  T. Urakami,et al.  Comprehensive molecular analysis of Japanese patients with pediatric‐onset MODY‐type diabetes mellitus , 2012, Pediatric diabetes.

[24]  W J Schull,et al.  Diabetes among Mexican Americans in Starr County, Texas. , 1983, American journal of epidemiology.

[25]  S. Gygi,et al.  SUMOylation of Pancreatic Glucokinase Regulates Its Cellular Stability and Activity* , 2013, The Journal of Biological Chemistry.

[26]  H. Kang,et al.  Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.

[27]  A. Hattersley,et al.  Genetic cause of hyperglycaemia and response to treatment in diabetes , 2003, The Lancet.

[28]  J. Blangero,et al.  Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. , 1996, Circulation.

[29]  A. Molven,et al.  Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[31]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[32]  A. Molven,et al.  MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X). , 2000, Biochemical and biophysical research communications.

[33]  T. Utsugi,et al.  Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese , 1998, Journal of Human Genetics.

[34]  A. Molven,et al.  Hepatocyte Nuclear Factor-1α Gene Mutations and Diabetes in Norway , 2003 .

[35]  S. Ellard.  Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. , 2000, Human mutation.

[36]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[37]  Todd A. Johnson,et al.  Genome-wide association study identifies three novel loci for type 2 diabetes. , 2014, Human molecular genetics.

[38]  M. McCarthy,et al.  Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes , 2012, Diabetologia.

[39]  G. Marchesini,et al.  Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes , 2010, Diabetes Care.

[40]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[41]  B. Shields,et al.  Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.

[42]  S. Haffner,et al.  Diabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites. , 2011, Annals of epidemiology.

[43]  J. Vandekerckhove,et al.  A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. , 1990, Nucleic acids research.

[44]  P. Njølstad,et al.  Hyperexcitability to sulphonylurea in MODY3 , 1998, Diabetologia.

[45]  D. Falconer.  The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus , 1967, Annals of human genetics.

[46]  Tanya M. Teslovich,et al.  Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico , 2013, Nature.

[47]  J. Susanto.  Maturity-onset Diabetes of the Young (MODY) , 2014 .

[48]  Karen Nuytemans,et al.  Whole Exome Sequencing , 2020, Definitions.

[49]  K. Xiang,et al.  [Scanning HNF-1 alpha gene mutation in Chinese early-onset and/or multiplex diabetes pedigrees]. , 2004, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[50]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[51]  A. Molven,et al.  Role of molecular genetics in transforming diagnosis of diabetes mellitus , 2011, Expert review of molecular diagnostics.

[52]  S. Barquera,et al.  Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. , 2003, Archives of medical research.

[53]  M. Daly,et al.  Genetic Mapping in Human Disease , 2008, Science.

[54]  Xihong Lin,et al.  Optimal tests for rare variant effects in sequencing association studies. , 2012, Biostatistics.

[55]  Á. Hreidarsson,et al.  MODY in Iceland is associated with mutations in HNF-1α and a novel mutation in NeuroD1 , 2001, Diabetologia.

[56]  G. Crabtree,et al.  HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. , 1990, Genes & development.

[57]  Søren Brunak,et al.  Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. , 2013, American journal of human genetics.